| Literature DB >> 20010727 |
Valère J Goossens1, Steve A deJager, Gert E Grauls, Marij Gielen, Robert F Vlietinck, Catherine A Derom, Ruth J F Loos, Sander S Rensen, Wim A Buurman, Jan W Greve, Marleen A van Baak, Petra F Wolffs, Cathrien A Bruggeman, Christian J P A Hoebe.
Abstract
Adenovirus infection has been shown to increase adiposity in chickens, mice, and nonhuman primates. Adenovirus type 36 (Ad-36) DNA was detected in adipose tissues in these animal trials. In the United States, Ad-36 significantly correlates with obesity as illustrated by an Ad-36 seroprevalence of 30% in obese individuals and 11% in nonobese individuals. We investigated the possibility of a similar correlation of Ad-36 in Dutch and Belgian persons. In total, 509 serum samples were analyzed for Ad-36 antibodies using a serum neutralization assay. In addition, PCR was used to detect adenoviral DNA in visceral adipose tissue of 31 severely obese surgical patients. Our results indicated an overall Ad-36 seroprevalence of 5.5% increasing with age. BMI of Ad-36 seropositive humans was not significantly different from seronegative humans. No adenoviral DNA could be found using PCR on visceral adipose tissue. In conclusion, this first Ad-36 study in the Netherlands and in Belgium indicates that Ad-36 does not play a role as a direct cause of BMI increase and obesity in humans in Western Europe.Entities:
Mesh:
Substances:
Year: 2009 PMID: 20010727 DOI: 10.1038/oby.2009.452
Source DB: PubMed Journal: Obesity (Silver Spring) ISSN: 1930-7381 Impact factor: 5.002